Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Population Screening, Public Health & Cost-Effectiveness Tools
Interactive worksheet14 clinical inputsPatient data not stored

Cost-Effectiveness of Statin Therapy by Age Risk Model Calculator

Cost-Effectiveness of Statin Therapy by Age/Risk Model: Explanation and Clinical Context This calculator implements a transparent, adjustable cost-effectiveness framework for primary-prevention statin therapy anchored to a patient’s 10-year ASCVD risk and therapy intensity. It estimates absolute risk reduction as baseline risk × RRR and converts events prevented into QALYs. Treatment disutility and excess diabetes ri

Interactive worksheet

Clinical inputs

0/14 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

Cost-Effectiveness of Statin Therapy by Age/Risk Model: Explanation and Clinical Context This calculator implements a transparent, adjustable cost-effectiveness framework for primary-prevention statin therapy anchored to a patient’s 10-year ASCVD risk and therapy intensity. It estimates absolute risk reduction as baseline risk × RRR and converts events prevented into QALYs. Treatment disutility and excess diabetes risk reduce net QALYs.

Costs include drug, monitoring, and offset by events avoided. Outputs: net QALYs, net costs, ICER, NMB, and decision vs WTP threshold.

Evidence & references2 primary sources mapped
  1. Source 1

    Pandya A, et al. JAMA. 2015;314:142–150. CTT Collaboration. Lancet. 2012;380:581–590. Mihaylova B, et al. Heart/BMJ Open-access summary.

  2. Source 2

    ACC/AHA Guideline background, Pooled Cohort Equations, 2024 update.

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

Cardiovascular Risk SCORE Calculator

Population Screening, Public Health & Cost-Effectiveness Tools
Interactive worksheet

Community Cholesterol Program Impact Calculator

Population Screening, Public Health & Cost-Effectiveness Tools
Interactive worksheet

Mobile Clinic Detection Probability Index (Rural CAD Screening) Calculator

Population Screening, Public Health & Cost-Effectiveness Tools
Interactive worksheet

Population Lp(a) Screening Benefit Estimator

Population Screening, Public Health & Cost-Effectiveness Tools
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.